Anaesthesia and Critical Care 2023: Official UK Launch for Deltex Medical’s TrueVue Haemodynamic Monitoring System
Over 1200 health professionals are expected to attend this year’s Anaesthesia and Critical Care Conference at London’s ExCel on November 14th/15th. Deltex Medical’s haemodynamic monitoring experts will be on stand K91.
This year’s conference marks the official UK launch of Deltex Medical’s new TrueVue™ haemodynamic monitoring system.
Precise, proven and now portable, TrueVue™ retains oesophageal Doppler monitoring (ODM+) technology at its heart. With its unparalleled clinical pedigree, the power of ODM+ is now even easier to deliver and applicable in more clinical settings than ever.
From its new user-friendly touchscreen interface to its battery-powered portability, the new product represents the biggest raft of changes to Deltex’s core system. Indeed Deltex claims that this is now the easiest to learn, simplest to use haemodynamic imaging technology ever.
CEO Andy Mears says; “The clinical standard for beat-to-beat ultrasound imaging of cardiac output has taken a leap forward in terms of usability and application.”
Key changes to TrueVue™:
- Haemodynamic monitoring in all settings: Compact new system is now portable and battery powered, making TrueVue applicable in a much broader range of clinical situations.
- Signal acquisition: Completely redeveloped signal processing with enhanced noise reduction (Dopplink).
- Signal maintenance: New Probe Holder ensures probe remains in desired orientation.
- Full control of your data: HD Touchscreen with completely redesigned, intuitive user interface.
Delegates are invited to visit Deltex Medical on stand K91 where the company’s experts will be on hand to demonstrate the new TrueVue™ system.
New TrueVue: Another milestone on the mission to eliminate complications caused by haemodynamic instability.